CIK 0001401040 · Non-accelerated filer<br>Smaller reporting company
DiaMedica Therapeutics Inc.
Sign in to watch- Ticker
- DMAC
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Canada (Federal Level)
- Entity type
- operating
- Phone
- (763) 496-5454
- Business address
- 301 CARLSON PARKWAY, SUITE 210, MINNEAPOLIS, MN, 55305
- Former names
- DiaMedica Inc.
- 4 Grant or award Director acquired 17,156 shares (grant or award)
- 4 Grant or award Director acquired 55,555 shares (grant or award)
- 4 Open-market buy Director bought 57,079 shares at an average $1.42 ($81,023)
- 4 Open-market buy Director bought 24,874 shares at an average $1.40 ($34,709)
- SC 13G/A Stake Amended Statement of Ownership
- 4 Open-market buy 10% owner bought 2,855,847 shares at $1.24 ($3,526,971)
- 4 Open-market buy Director bought 35,000 shares at $1.39 ($48,493)
- 4 Open-market buy Director bought 819 shares at $1.19 ($975)
- 4 Open-market buy Director bought 67,228 shares at an average $1.20 ($80,463)
- 4 Open-market buy President and CEO bought 20,000 shares at $1.21 ($24,200)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 8-K Event Results of operations · Other events
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- S-8 Other Securities Offered to Employees in Benefit Plans
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Open-market buy 10% owner bought 207,974 shares at $1.33 ($275,898)
- 3 Insider Initial Statement of Ownership
Page 11 of 22 · 429 filings